Westford, MA, United States of America

Nivedita Namdev

USPTO Granted Patents = 21 


 

Average Co-Inventor Count = 7.6

ph-index = 5

Forward Citations = 78(Granted Patents)


Company Filing History:


Years Active: 2009-2021

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):

Title: Innovations of Nivedita Namdev: Pioneering Patents in Pharmaceuticals

Introduction

Nivedita Namdev, based in Westford, MA, is an innovative inventor renowned for her contributions to the pharmaceutical sector. With a remarkable total of 21 patents to her name, Nivedita has made significant strides in drug development, emphasizing the modulation of biological processes.

Latest Patents

Among her latest innovations is the patent for Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof. This application pertains to a unique compound that modulates the activity of BTK (Bruton’s tyrosine kinase), a crucial player in various diseases. The compound, along with its pharmaceutically acceptable salts, derivatives, and analogs, represents a significant advancement in therapeutic methods aimed at treating or preventing diseases where BTK operates.

Career Highlights

Nivedita has established herself as a pivotal figure in her field while working at Arqule, Inc. Her research and patenting activities reflect her dedication to innovative solutions that enhance medical treatments and patient outcomes.

Collaborations

Throughout her career, Nivedita has collaborated with esteemed colleagues, including Jean-Marc Lapierre and Manish Tandon. These partnerships underscore her commitment to teamwork and innovation, driving forward the frontiers of pharmaceutical research and development.

Conclusion

Nivedita Namdev's impact in the pharmaceutical industry through her numerous patents highlights her role as a pioneer in innovation. Her work not only contributes to scientific knowledge but also aims to improve lives by developing new therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…